Zevra has sold its US Food and Drug Administration (FDA) priority review voucher (PRV) for $150m to an undisclosed party.

Zevra Therapeutics has inked a deal to sell its Food and Drug Administration priority-review voucher to an undisclosed buyer for gross proceeds of $150 million.

For Zevra Therapeutics, last year’s approval of the rare lysosomal storage disorder drug Miplyffa appears to be the gift that ...

Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced that it has entered ...

ACAD reports mixed fourth-quarter results as earnings missed estimates while revenues beat the same, driven by year-over-year growth in Nuplazid and Daybue sales.

New Delhi: Union Home Minister Amit Shah on Friday spoke to Uttarakhand Chief Minister Pushkar Singh Dhami and took stock of ...

Trump’s border crackdown faces hurdles as immigration judges are terminated. Scripps News spoke with one of those terminated ...

From the top spy agency's biggest concern to two senators butting heads, here are some of the key moments from Senate ...

The Harborside's financial collapse underscores the challenges continuing care retirement communities face and the financial ...

AI's financial plan for me managed to both overpay my debts and allocate more than my income to achieve my goals.

In our CIT Savings Account review, we gauge the online bank's savings and money market accounts. Discover its rates, fees, ...

Cyber Heater is a portable ceramic heater used in a medium sized room. It is a wall outlet portable heater with remote ...